Brief: Pfizer Inc Reports Passive Stake Of 4.96% In Tourmaline Bio Inc As Of Jan 29
March 15 (Reuters) - Pfizer Inc PFE.N :
* PFIZER INC REPORTS PASSIVE STAKE OF 4.96% IN TOURMALINE
BIO INC
AS OF JAN 29, 2024 VERSUS. 6.26% AS OF OCT 19, 2023
Source text for Eikon: ID:n0000078003-24-000075
Further company coverage: PFE.N
((reuters.briefs@thomsonreuters.com;))
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy